Literature DB >> 32119806

High-Fat Diet Increases Fat Oxidation and Promotes Skeletal Muscle Fatty Acid Transporter Expression in Exercise-Trained Mice.

Hea-Yeon Yun1, Taein Lee2, Yoonhwa Jeong1,3.   

Abstract

The aim of this study was to investigate the effect of a high-fat diet (HFD) on energy substrate utilization during long-term endurance exercise in mice. Male ICR mice (n = 32; 6 weeks old) were divided into two groups: low-fat diet (LFD, n = 16) and HFD (n = 16) and acclimatized to LFD or HFD feeding over 12 weeks. After 12 weeks, the two dietary groups were each divided into two groups with or without exercise (EX): LF-CON, LF-EX, HF-CON, and HF-EX groups. The exercise groups were trained to run on a treadmill for 12 weeks. At the end of the experimental protocol, energy metabolism in the whole body was measured at rest for 24 h and during exercise for 1 h using respiratory gas analysis. Furthermore, molecules involved in skeletal muscle fat metabolism were analyzed. Substrate utilization for energy metabolism in the whole body indicated that fat utilization was high in HFD intake. Notably, when HFD intake and exercise were combined, fat utilization was markedly increased during endurance exercise. In contrast, exercise showed no effect when combined with LFD intake. The gene expressions of Fat/Cd36, Fatp1, Fabp-pm, and Cpt1 were upregulated by HFD intake, with Fat/Cd36 and Cpt1 considerably elevated during long-term endurance exercise. In contrast, exercise showed no effect when combined with LFD intake. These results suggest that HFD intake effectively increased fat utilization as an energy substrate during long-term endurance exercise.

Entities:  

Keywords:  endurance exercise; fat oxidation; fatty acid transporter; high-fat diet; skeletal muscle

Year:  2020        PMID: 32119806     DOI: 10.1089/jmf.2019.4651

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  5 in total

1.  GPAT Gene Silencing in Muscle Reduces Diacylglycerols Content and Improves Insulin Action in Diet-Induced Insulin Resistance.

Authors:  Iwona Kojta; Piotr Zabielski; Kamila Roszczyc-Owsiejczuk; Monika Imierska; Emilia Sokołowska; Agnieszka Błachnio-Zabielska
Journal:  Int J Mol Sci       Date:  2020-10-06       Impact factor: 5.923

2.  Camphene Attenuates Skeletal Muscle Atrophy by Regulating Oxidative Stress and Lipid Metabolism in Rats.

Authors:  Suji Baek; Jisu Kim; Byung Seok Moon; Sun Mi Park; Da Eun Jung; Seo Young Kang; Sang Ju Lee; Seung Jun Oh; Seung Hae Kwon; Myung Hee Nam; Hye Ok Kim; Hai Jeon Yoon; Bom Sahn Kim; Kang Pa Lee
Journal:  Nutrients       Date:  2020-12-03       Impact factor: 5.717

3.  Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS.

Authors:  Michael Sloth Trabjerg; Dennis Christian Andersen; Pam Huntjens; Kirsten Egelund Oklinski; Luise Bolther; Jonas Laugård Hald; Amalie Elton Baisgaard; Kasper Mørk; Nikolaj Warming; Ulla Bismark Kullab; Lona John Kroese; Colin Eliot Jason Pritchard; Ivo Johan Huijbers; John Dirk Vestergaard Nieland
Journal:  Commun Biol       Date:  2021-04-30

4.  Serine Palmitoyltransferase Gene Silencing Prevents Ceramide Accumulation and Insulin Resistance in Muscles in Mice Fed a High-Fat Diet.

Authors:  Monika Imierska; Piotr Zabielski; Kamila Roszczyc-Owsiejczuk; Emilia Sokołowska; Karolina Pogodzińska; Iwona Kojta; Agnieszka Błachnio-Zabielska
Journal:  Cells       Date:  2022-03-26       Impact factor: 6.600

5.  Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models.

Authors:  Michael Sloth Trabjerg; Anne Skøttrup Mørkholt; Jacek Lichota; Michal Krystian Egelund Oklinski; Dennis Christian Andersen; Katrine Jønsson; Kasper Mørk; Marie-Louise Nibelius Skjønnemand; Lona John Kroese; Colin Eliot Jason Pritchard; Ivo Johan Huijbers; Parisa Gazerani; Angelique Corthals; John Dirk Vestergaard Nieland
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.